These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23598816)

  • 1. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.
    Brazil JC; Louis NA; Parkos CA
    Inflamm Bowel Dis; 2013 Jun; 19(7):1556-65. PubMed ID: 23598816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
    Zhou GX; Liu ZJ
    J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking.
    Chin AC; Parkos CA
    Ann N Y Acad Sci; 2006 Aug; 1072():276-87. PubMed ID: 17057207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease.
    Nexoe AB; Pilecki B; Von Huth S; Husby S; Pedersen AA; Detlefsen S; Marcussen N; Moeller JB; Holmskov U; Sorensen GL
    Inflamm Bowel Dis; 2019 Jul; 25(8):1349-1356. PubMed ID: 30753482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine and cytokine levels in inflammatory bowel disease patients.
    Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
    Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases.
    Britzen-Laurent N; Weidinger C; Stürzl M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal barrier dysfunction in inflammatory bowel diseases.
    McGuckin MA; Eri R; Simms LA; Florin TH; Radford-Smith G
    Inflamm Bowel Dis; 2009 Jan; 15(1):100-13. PubMed ID: 18623167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration.
    Chin AC; Lee WY; Nusrat A; Vergnolle N; Parkos CA
    J Immunol; 2008 Oct; 181(8):5702-10. PubMed ID: 18832729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets.
    Dos Santos Ramos A; Viana GCS; de Macedo Brigido M; Almeida JF
    Pharmacol Res; 2021 Sep; 171():105779. PubMed ID: 34298111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease.
    Zhou G; Yu L; Yang W; Wu W; Fang L; Liu Z
    Mediators Inflamm; 2016; 2016():2543070. PubMed ID: 27721573
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory bowel disease: beyond the boundaries of the bowel.
    Actis GC; Rosina F; Mackay IR
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of IBD associated diarrhea.
    Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
    Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
    Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
    Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis.
    Ghimire J; Iftikhar R; Penrose HM; Snarski P; Ruiz E; Savkovic SD
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.